NCT06355661View on ClinicalTrials.gov

A Study for Assessing the Efficacy and Safety ParActin® in Individuals With Upper Respiratory Tract Infections

NARecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

April 5, 2024

Primary Completion Date

July 15, 2024

Study Completion Date

July 30, 2024

Conditions
Upper Respiratory Tract Infections
Interventions
DIETARY_SUPPLEMENT

ParActin®: 300 mg + MCC: 100 mg (± 10%) per Capsule

Two capsules/day (One capsule to be taken 30 minutes before breakfast \& one capsule to be taken 30 minutes before dinner)

DIETARY_SUPPLEMENT

MCC: 400 mg (± 10%) per Capsule

Two capsules/day (One capsule to be taken 30 minutes before breakfast \& one capsule to be taken 30 minutes before dinner)

Trial Locations (9)

110027

RECRUITING

Good health Clinic, Delhi

110094

RECRUITING

Tulsi Multispecility Hospital, Delhi

221005

RECRUITING

Shubham Sudbhawana Super Speciality Hospital, Varanasi

221011

NOT_YET_RECRUITING

Janta Hospital, Varanasi

226012

RECRUITING

Human Care Hospital, Lucknow

305001

RECRUITING

Jawaharlal Nehru Medical College, Ajmer

411045

RECRUITING

ENT Vertigo Clinic, Pune

422009

RECRUITING

Life care hospital, Nashik

110015.

RECRUITING

Gastron Clinic, Delhi

All Listed Sponsors
lead

Vedic Lifesciences Pvt. Ltd.

INDUSTRY